Skip to main content
. 2017 Mar 30;8(3):e2714. doi: 10.1038/cddis.2017.134

Figure 5.

Figure 5

miR-491-5p inhibits gastric cancer progression in vivo. (a) At day 30, tumor growth was measured by in vivo bioluminescence imaging. The armpits were injected with SGC-7901 cells infected with LV-miR-ctrl (left armpit) and SGC-7901 cells infected with LV-miR-491 (right armpit) in four nude mice, respectively. (b) The gross morphology of tumors. (c) The expression levels of miR-491-5p were analyzed by qRT-PCR analysis in the tumor tissues from the animals. (d) Tumor weight was measured. (e) Tumor growth curves of tumor volume were formed every 3 days for 30 days (n=4). (f) The expression levels of Wnt3a were analyzed by western blot in tissues from the animals (*P<0.05, **P<0.01)